Clearpoint Neuro Inc reports results for the quarter ended in March - Earnings Summary

Clearpoint Neuro

12/05/2022 04:47

* Clearpoint Neuro Inc  CLPT.OQ  reported a quarterly
adjusted
loss of 17 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 20 cents per share.
    * Revenue rose 24.8% to $5.03 million from a year ago; 
analysts
expected $4.18 million. 
    * Clearpoint Neuro Inc's reported EPS for the quarter was a
loss
of 17 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Clearpoint Neuro Inc shares had fallen by 26.4% this
quarter and
lost 31.7% so far this year.
    * The company reported a quarterly loss of $3.96 million.
    * Wall Street's median 12-month price target for Clearpoint
Neuro
Inc is $18.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 12 at 03:47 a.m.  ​All
figures in US dollars unless otherwise stated